Internal Medicine, Cardiovascular Disease · Bend, OR
NPI
1669582870
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2500 NE Neff Rd
Bend, OR, 97701
Phone (541) 388-4333
Groups this clinician bills Medicare through
Medicare paid, 2024
$393K
9,503 services
Medicare patients, 2024
2,282
Average age 75
Drug cost, 2024
$978K
3,362 prescriptions
Company payments, 2025
$1,146
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ian C Riddock was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 3,000 times for 30 patients. In total Ian C Riddock billed 9,503 services in 104 codes, and Medicare paid $393K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,000 | 30 | $0.10 | $312 |
| 93000 Electrocardiogram | Office | 1,021 | 956 | $9.79 | $9,992 |
| 93306 Echocardiography (TTE/TEE) | Office | 646 | 631 | $138.01 | $89K |
| 75571 CT/CTA - Chest | Office | 414 | 413 | $68.77 | $28K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 356 | 89 | $5.13 | $1,827 |
| 93296 External Electrocardiographic Monitoring | Office | 342 | 119 | $14.67 | $5,017 |
| 99214 Office E&M - Established | Office | 274 | 240 | $92.93 | $25K |
| 93294 External Electrocardiographic Monitoring | Office | 265 | 97 | $19.85 | $5,259 |
| 93248 Electrocardiogram | Office | 186 | 185 | $17.20 | $3,200 |
| 36415 Venipuncture Blood Collection | Office | 179 | 149 | $8.61 | $1,541 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 177 | 161 | $12.34 | $2,184 |
| 93246 Electrocardiogram | Office | 174 | 173 | $8.78 | $1,527 |
| 99233 Hospital E&M - Subsequent | Facility | 149 | 73 | $88.79 | $13K |
| 93015 Electrocardiogram | Office | 149 | 148 | $47.69 | $7,106 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 146 | 145 | $33.26 | $4,855 |
By year: 2022 $513K for 8,944 services; 2023 $419K for 8,656 services; 2024 $393K for 9,503 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 179 | 149 | $8.61 | $1,541 |
| 80061 Clinical Chemistry | 137 | 130 | $13.12 | $1,797 |
| 80048 Clinical Chemistry | 40 | 32 | $8.29 | $332 |
| 83880 Clinical Chemistry | 32 | 30 | $38.47 | $1,231 |
| 82565 Clinical Chemistry | 12 | 11 | $5.02 | $60.24 |
| 80053 Clinical Chemistry | 11 | 11 | $10.35 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Ian C Riddock prescribed most often to Medicare patients was Ezetimibe, with 810 prescriptions and refills. In total Ian C Riddock wrote 3,362 Medicare prescriptions that cost $978K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 810 | 2,357 | 298 | $35K |
| Rosuvastatin Calcium Generic | 543 | 1,578 | 192 | $14K |
| Atorvastatin Calcium Generic | 233 | 689 | 86 | $3,874 |
| Metoprolol Succinate Generic | 229 | 649 | 85 | $3,317 |
| Eliquis Apixaban | 210 | 484 | 59 | $275K |
| Jardiance Empagliflozin | 159 | 426 | 61 | $240K |
| Spironolactone Generic | 150 | 420 | 53 | $1,307 |
| Repatha Sureclick Evolocumab | 122 | 226 | 29 | $126K |
| Amlodipine Besylate Generic | 89 | 238 | 37 | $594 |
| Losartan Potassium Generic | 84 | 251 | 35 | $915 |
| Carvedilol Generic | 51 | 150 | 20 | $326 |
| Xarelto Rivaroxaban | 49 | 117 | 14 | $63K |
| Flecainide Acetate Generic | 47 | 119 | 19 | $2,743 |
| Ozempic Semaglutide | 40 | 58 | Under 11 | $55K |
| Entresto Sacubitril/Valsartan | 38 | 93 | 15 | $59K |
Brand drugs: 744 claims; generic drugs: 2,618 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ian C Riddock $1,146 ($1,146 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $348.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 4 | $348 |
| Abbott Laboratories ABT | 3 | $136 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $107 |
| AtriCure, Inc. ATRC | 1 | $104 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $103 |
| Esperion Therapeutics, Inc. ESPR | 1 | $98.38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $94.08 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $92.49 |
| Novo Nordisk Inc NVO | 1 | $23.09 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.